Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the PKC inhibitor ruboxistaurin
Rebecca Dowey, Joby Cole, A A Roger Thompson, Chenghao Huang, Jacob Whatmore, Ahmed Iqbal, Kirsty L Bradley, Joanne McKenzie, Rebecca C Hull, Allan Lawrie, Alison M Condliffe, Endre Kiss-Toth, Ian Sabroe, Lynne R Prince
doi: https://doi.org/10.1101/2021.08.24.21262336
Rebecca Dowey
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
Joby Cole
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
2Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
A A Roger Thompson
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
Chenghao Huang
3Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom
Jacob Whatmore
3Faculty of Medicine, Dentistry and Health, University of Sheffield, Sheffield, United Kingdom
Ahmed Iqbal
2Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
4Department of Oncology and Metabolism, University of Sheffield, Sheffield, United Kingdom
Kirsty L Bradley
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
Joanne McKenzie
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
Rebecca C Hull
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
Allan Lawrie
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
Alison M Condliffe
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
Endre Kiss-Toth
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
Ian Sabroe
2Sheffield Teaching Hospitals NHS Foundation Trust, Sheffield, United Kingdom
Lynne R Prince
1Department of Infection, Immunity and Cardiovascular Disease, University of Sheffield, Sheffield, United Kingdom
Article usage
Posted August 26, 2021.
Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the PKC inhibitor ruboxistaurin
Rebecca Dowey, Joby Cole, A A Roger Thompson, Chenghao Huang, Jacob Whatmore, Ahmed Iqbal, Kirsty L Bradley, Joanne McKenzie, Rebecca C Hull, Allan Lawrie, Alison M Condliffe, Endre Kiss-Toth, Ian Sabroe, Lynne R Prince
medRxiv 2021.08.24.21262336; doi: https://doi.org/10.1101/2021.08.24.21262336
Enhanced neutrophil extracellular trap formation in COVID-19 is inhibited by the PKC inhibitor ruboxistaurin
Rebecca Dowey, Joby Cole, A A Roger Thompson, Chenghao Huang, Jacob Whatmore, Ahmed Iqbal, Kirsty L Bradley, Joanne McKenzie, Rebecca C Hull, Allan Lawrie, Alison M Condliffe, Endre Kiss-Toth, Ian Sabroe, Lynne R Prince
medRxiv 2021.08.24.21262336; doi: https://doi.org/10.1101/2021.08.24.21262336
Subject Area
Subject Areas
- Addiction Medicine (375)
- Allergy and Immunology (690)
- Anesthesia (184)
- Cardiovascular Medicine (2767)
- Dermatology (236)
- Emergency Medicine (415)
- Epidemiology (12420)
- Forensic Medicine (10)
- Gastroenterology (785)
- Genetic and Genomic Medicine (4285)
- Geriatric Medicine (396)
- Health Economics (702)
- Health Informatics (2765)
- Health Policy (1025)
- Hematology (370)
- HIV/AIDS (880)
- Medical Education (404)
- Medical Ethics (113)
- Nephrology (455)
- Neurology (4061)
- Nursing (218)
- Nutrition (602)
- Oncology (2143)
- Ophthalmology (607)
- Orthopedics (251)
- Otolaryngology (313)
- Pain Medicine (256)
- Palliative Medicine (77)
- Pathology (479)
- Pediatrics (1151)
- Primary Care Research (471)
- Public and Global Health (6667)
- Radiology and Imaging (1455)
- Respiratory Medicine (887)
- Rheumatology (425)
- Sports Medicine (353)
- Surgery (466)
- Toxicology (57)
- Transplantation (194)
- Urology (171)